Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Pfeiffer

Showing results (471-480 of 528) with videos related to

Pageof 53
Sort By:
Obesity Pillars|January 8, 2026
Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement using a modified Delphi approachJ L Sievenpiper, J Ard, M Blüher, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 27, 2014
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?R Schennach, M Riedel, M Obermeier, et al.
Journal of Cell Communication and Signaling|November 13, 2017
Assessment of circulating Wnt1 inducible signalling pathway protein 1 (WISP-1)/CCN4 as a novel biomarker of obesityChristopher Tacke, Krasimira Aleksandrova, Miriam Rehfeldt, et al.
Diabetes|July 6, 2021
Insulin Directly Regulates the Circadian Clock in Adipose TissueNeta Tuvia, Olga Pivovarova-Ramich, Veronica Murahovschi, et al.
Nutrition & Metabolism|January 9, 2019
An 8-week diet high in cereal fiber and coffee but free of red meat does not improve beta-cell function in patients with type 2 diabetes mellitus: a randomized controlled trialYanislava Karusheva, Lejla Kunstein, Alessandra Bierwagen, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 1, 2012
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorderR Schennach, S Meyer, F Seemüller, et al.
European Journal of Clinical Nutrition|June 20, 2013
Experience and acceptability of diets of varying protein content and glycemic index in an obese cohort: results from the Diogenes trialA McConnon, G W Horgan, C Lawton, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 28, 2013
Impact of weight loss and maintenance with ad libitum diets varying in protein and glycemic index content on metabolic syndromeAngeliki Papadaki, Manolis Linardakis, Maria Plada, et al.
The Journal of Clinical Endocrinology and Metabolism|November 23, 2006
Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36P T Pfluger, J Kampe, T R Castaneda, et al.
Acta Psychiatrica Scandinavica|October 30, 2010
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression ScaleR Schennach-Wolff, M Obermeier, F Seemüller, et al.
Pageof 53

Showing results (471-480 of 528) with videos related to

Sort By:
Pageof 53
Obesity Pillars|January 8, 2026
Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement using a modified Delphi approachJ L Sievenpiper, J Ard, M Blüher, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 27, 2014
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?R Schennach, M Riedel, M Obermeier, et al.
Journal of Cell Communication and Signaling|November 13, 2017
Assessment of circulating Wnt1 inducible signalling pathway protein 1 (WISP-1)/CCN4 as a novel biomarker of obesityChristopher Tacke, Krasimira Aleksandrova, Miriam Rehfeldt, et al.
Diabetes|July 6, 2021
Insulin Directly Regulates the Circadian Clock in Adipose TissueNeta Tuvia, Olga Pivovarova-Ramich, Veronica Murahovschi, et al.
Nutrition & Metabolism|January 9, 2019
An 8-week diet high in cereal fiber and coffee but free of red meat does not improve beta-cell function in patients with type 2 diabetes mellitus: a randomized controlled trialYanislava Karusheva, Lejla Kunstein, Alessandra Bierwagen, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 1, 2012
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorderR Schennach, S Meyer, F Seemüller, et al.
European Journal of Clinical Nutrition|June 20, 2013
Experience and acceptability of diets of varying protein content and glycemic index in an obese cohort: results from the Diogenes trialA McConnon, G W Horgan, C Lawton, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 28, 2013
Impact of weight loss and maintenance with ad libitum diets varying in protein and glycemic index content on metabolic syndromeAngeliki Papadaki, Manolis Linardakis, Maria Plada, et al.
The Journal of Clinical Endocrinology and Metabolism|November 23, 2006
Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36P T Pfluger, J Kampe, T R Castaneda, et al.
Acta Psychiatrica Scandinavica|October 30, 2010
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression ScaleR Schennach-Wolff, M Obermeier, F Seemüller, et al.
Pageof 53